PF-07248144
- Generic Name
- PF-07248144
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Phase 1
Recruiting
- Conditions
- Locally Advanced or Metastatic Non-small Cell Lung CancerLocally Advanced or Metastatic Castration-resistant Prostate CancerLocally Advanced or Metastatic ER+ HER2- Breast Cancer
- Interventions
- First Posted Date
- 2020-10-28
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 186
- Registration Number
- NCT04606446
- Locations
- 🇨🇳
Beijing Cancer hospital, Beijing, Beijing, China
🇨🇳SUN Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
🇨🇳Hubei Cancer Hospital, Wuhan, Hubei, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath